Maximizing Investigator Meetings – Maximizing Investigator Meetings

Investigator meetings are essential for successfully training clinical sites. These meetings directly affect a pharmaceutical company’s ability to collect accurate data that clearly indicates the safety and efficacy of a drug. Successful investigator meetings are often correlated to the success of Phase II/III, which are essential to new drug development. In addition to essential clinical training about the new drugs, investigator meetings can provide an in-person occasion for study participants get to know each other and form a real “team” going forward.

To train physicians and their staff on all aspects of the protocol, investigator meetings introduce the researchers to each other and the study and provide training on how to conduct the study. The program content should provide the participants with a solid understanding of the protocol: inclusion/exclusion criteria, procedures related to each visit, adverse-event reporting, lab procedures, and recruitment strategies. Most important is to communicate all this information in the most time-efficient and engaging manner. ExL’s Maximizing Investigator Meetings conference is the premier conference dedicated to developing effective and engaging investigator meetings.

Who Should Attend

This conference is designed for representatives from pharmaceutical, medical device, and biotechnology companies with responsibilities in the following areas:

  • Investigator Meetings
  • Clinical Research/Operations/Outsourcing/Affairs
  • Medical Affairs
  • Medical Science Liaison
  • Clinical Science Liaison
  • Early-Phase Research/Development
  • Meeting Planning
  • Pharmacology/Pharmacokinetics/Pharmacodynamics
  • Pharmacovigilance
  • Translational/Experimental Medicine
  • Biostatistics/Biometrics
  • Pharmacometrics
  • Clinical Data Management/Statistics
  • Clinical Innovation
  • Regulatory Affairs/Compliance
  • Medical Research/Affairs
  • Patient Recruitment/Engagement
  • Drug Safety

This conference is also of interest to:

  • Clinical Research Organizations
  • Clinical/Quality Risk Consultants
  • Medical Informatics Companies
  • Functional Service Providers
  • Patient Engagement and Retention Services
  • Clinical Technology and Data Management Solution Providers
End Date

Address : Investigator Meetings Forum